Efficacy according to blind independent central review:...

Lung Cancer 2017 / 02 Vol. 104

Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC

Wu, Yi-Long, Saijo, Nagahiro, Thongprasert, Sumitra, Yang, J. C.-H., Han, Baohui, Margono, Benjamin, Chewaskulyong, Busayamas, Sunpaweravong, Patrapim, Ohe, Yuichiro, Ichinose, Yukito, Yang, Jin-Ji, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
104
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2016.11.022
Date:
February, 2017
File:
PDF, 929 KB
english, 2017
Conversion to is in progress
Conversion to is failed